DK0760668T3 - Anvendelse af magnesiumbaserede produkter til behandling eller forebyggelse af neoplastiske og autoimmune sygdomme - Google Patents

Anvendelse af magnesiumbaserede produkter til behandling eller forebyggelse af neoplastiske og autoimmune sygdomme

Info

Publication number
DK0760668T3
DK0760668T3 DK95920208T DK95920208T DK0760668T3 DK 0760668 T3 DK0760668 T3 DK 0760668T3 DK 95920208 T DK95920208 T DK 95920208T DK 95920208 T DK95920208 T DK 95920208T DK 0760668 T3 DK0760668 T3 DK 0760668T3
Authority
DK
Denmark
Prior art keywords
magnesium
pharmaceutically acceptable
salt
treat
magnesium salt
Prior art date
Application number
DK95920208T
Other languages
Danish (da)
English (en)
Inventor
Giampiero Valletta
Original Assignee
Giampiero Valletta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giampiero Valletta filed Critical Giampiero Valletta
Application granted granted Critical
Publication of DK0760668T3 publication Critical patent/DK0760668T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95920208T 1994-05-25 1995-05-24 Anvendelse af magnesiumbaserede produkter til behandling eller forebyggelse af neoplastiske og autoimmune sygdomme DK0760668T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM940328A IT1272994B (it) 1994-05-25 1994-05-25 Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-
PCT/IT1995/000089 WO1995031991A2 (en) 1994-05-25 1995-05-24 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases

Publications (1)

Publication Number Publication Date
DK0760668T3 true DK0760668T3 (da) 2003-03-31

Family

ID=11402556

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95920208T DK0760668T3 (da) 1994-05-25 1995-05-24 Anvendelse af magnesiumbaserede produkter til behandling eller forebyggelse af neoplastiske og autoimmune sygdomme

Country Status (15)

Country Link
US (2) US6248368B1 (ru)
EP (1) EP0760668B1 (ru)
JP (1) JP3721196B2 (ru)
KR (1) KR100363031B1 (ru)
CN (1) CN1111414C (ru)
AT (1) ATE229809T1 (ru)
AU (1) AU691617B2 (ru)
CA (1) CA2190847C (ru)
DE (1) DE69529213T2 (ru)
DK (1) DK0760668T3 (ru)
ES (1) ES2188663T3 (ru)
IT (1) IT1272994B (ru)
PT (1) PT760668E (ru)
RU (2) RU2163487C2 (ru)
WO (1) WO1995031991A2 (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1076197C (zh) * 1997-08-20 2001-12-19 许跃远 一种治疗乳腺疾病的药
US6639265B2 (en) 2000-01-26 2003-10-28 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device and method of manufacturing the semiconductor device
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
US7097860B2 (en) * 2001-08-03 2006-08-29 Aaron Moshenyat Method and composition for treatment of inflammatory and inflammation-related disorders
US6537590B1 (en) * 2002-02-19 2003-03-25 Troy J. Lee Solution and the method of making the same for the treatment of osteoarthritis
US7247328B2 (en) * 2002-05-31 2007-07-24 Zinpro Corporation Chromium (III) alpha amino acid complexes
US7129375B2 (en) * 2002-10-16 2006-10-31 Zinpro Corporation Metal complexes of α amino dicarboxylic acids
EP1684815B1 (en) * 2003-10-10 2008-12-17 KW2 Implantattechnologie GmbH Cartilage regeneration by generation of chondrons under high concentrations of magnesium
EP1522322A1 (en) * 2003-10-10 2005-04-13 Witte, Frank, Dr. Cartilage regeneration
WO2005077405A1 (en) * 2004-02-06 2005-08-25 Cancer Treatment International Compositions and methods for the treatment of cancer by systemic elevation of lactate and consequent depletion of arginine
US20060141054A1 (en) 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US8779175B2 (en) * 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
FI119101B (fi) * 2006-01-24 2008-07-31 Medgenerics Oy Magnesiumsuoloja sisältävä hoitoaine kasvainten tai vastaavien hoitoon ja magnesiumsulfaatin käyttö
US8945505B2 (en) * 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US8815232B2 (en) 2008-08-26 2014-08-26 Kyon Biotech Ag Compositions and methods for treating cancer
KR102075024B1 (ko) * 2018-01-25 2020-02-07 염창환 마그네슘 화합물을 유효성분으로 포함하는 항암보조제
CN108936149A (zh) * 2018-05-21 2018-12-07 胡宪蕴 一种含纳米硒的多元素复合补充剂及应用
CN109674819B (zh) * 2018-12-21 2023-05-05 博雅干细胞科技有限公司 胎盘间充质干细胞制剂及其治疗硬化病的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5244637A (en) * 1975-10-04 1977-04-07 Fuji Photo Optical Co Ltd Exposure information display device
US4975423A (en) * 1984-06-27 1990-12-04 Colgate-Palmolive Company Inhibition of tumor development
US5035888A (en) * 1988-11-09 1991-07-30 Tadataka Hara Therapeutically useful mineral composition
US5626883A (en) * 1994-04-15 1997-05-06 Metagenics, Inc. Ascorbic acid compositions providing enhanced human immune system activity

Also Published As

Publication number Publication date
RU2000132310A (ru) 2003-01-27
PT760668E (pt) 2003-04-30
CA2190847A1 (en) 1995-11-30
WO1995031991A3 (en) 1996-02-15
US6248368B1 (en) 2001-06-19
JP3721196B2 (ja) 2005-11-30
US6589564B2 (en) 2003-07-08
AU691617B2 (en) 1998-05-21
ITRM940328A1 (it) 1995-11-25
ES2188663T3 (es) 2003-07-01
KR970703155A (ko) 1997-07-03
KR100363031B1 (ko) 2003-04-10
US20010041191A1 (en) 2001-11-15
AU2574295A (en) 1995-12-18
DE69529213D1 (de) 2003-01-30
DE69529213T2 (de) 2003-11-13
EP0760668B1 (en) 2002-12-18
ITRM940328A0 (it) 1994-05-25
IT1272994B (it) 1997-07-01
EP0760668A1 (en) 1997-03-12
RU2163487C2 (ru) 2001-02-27
CN1111414C (zh) 2003-06-18
CA2190847C (en) 2004-03-16
CN1149255A (zh) 1997-05-07
JPH10500678A (ja) 1998-01-20
ATE229809T1 (de) 2003-01-15
WO1995031991A2 (en) 1995-11-30

Similar Documents

Publication Publication Date Title
DK0760668T3 (da) Anvendelse af magnesiumbaserede produkter til behandling eller forebyggelse af neoplastiske og autoimmune sygdomme
KR920000324A (ko) 필수 지방산 처리법
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
IT1255390B (it) Prodotti farmaceutici per curare malattie tumorali e procedimento per la loro preparazione
BR9908030A (pt) Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado
US20060233892A1 (en) Topiramate compositions for treatment of headache
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
GR3021866T3 (en) Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
MX9302038A (es) Metodo para el tratamiento del cancer por una terapia conjunta con derivados de 2-halometilideno y un agente antineoplasico especifico de fase m o fase s.
EP0690722A4 (en) COMPOSITION AND METHOD FOR REDUCING THE TOXICITY OF BIOLOGICALLY ACTIVE FACTORS
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
AU6681790A (en) Method and composition for treating inflammatory bowel disorders
EP0957925A4 (en) TREATMENT OF OSTEOARTHRITIS BY ADMINISTRATION OF POLY-N-ACETYL-D-GLUCOSAMINE
FR2712811B1 (fr) Procédé pour lutter contre l'adiposite et compositions utilisables à cet effet.
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
Eberl et al. Meclofenamate sodium in the treatment of acute gout. Results of a double-blind study
Ling et al. PUVA therapy in necrobiosis lipoidica diabeticorum
KR920702225A (ko) 약학 조성물
AU2002334001B2 (en) Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
JPS57126420A (en) Drug for digestive organ
GB2286528A (en) Dietary supplement
US4650668A (en) Composition for relieving toothache pain and other forms of intense pain
WO2001042205A3 (en) Treatment of inflammatory bowel disease with vitamin d compounds
Langloh Experience with piroxicam in general practice: results of a German multicenter study on 18,888 patients
CAMPBELL et al. Pharmacologic agents in the prevention of decompression sickness